Carotid artery intima-media thickness and lipid profile in adults with growth hormone deficiency after long-term growth hormone replacement

Metabolism: Clinical and Experimental

Volumn 54, Issue 3, 2005, Pages 321-329

  Soares, Débora Vieira ^a,b   Spina, Luciana Diniz Carneiro ^a   Brasil, Rosane Resende De Lima Oliveira ^a   Da Silva, Eliane Maria Carvalho ^a   Lobo, Priscila Marise ^a   Salles, Elizabeth ^a   Coeli, Claúdia Medina ^a   Conceição, Flávia Lúcia ^a   Vaisman, Mario ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; CHOLESTEROL; DESMOPRESSIN; GROWTH FACTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN GROWTH HORMONE; LEVOTHYROXINE; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDROXYPROGESTERONE ACETATE; PREDNISONE; SEX HORMONE; SOMATOMEDIN C; TESTOSTERONE ESTER; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTERY INTIMA PROLIFERATION; ARTICLE; BODY MASS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CRANIOPHARYNGIOMA; CUSHING SYNDROME; DRUG EFFECT; DYSGERMINOMA; ECHOGRAPHY; FEMALE; GROWTH HORMONE DEFICIENCY; HISTIOCYTOSIS X; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS ADENOMA; HYPOPITUITARISM; LIPOPROTEIN BLOOD LEVEL; MALE; PINEAL BODY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SIDE EFFECT; THICKNESS; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 13844277036     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2004.09.011     Document Type: Article

References (78)

1. T. Rosén, and B-.Å. Bengtsson Premature mortality due to cardiovascular disease in hypopituitarism Lancet 336 1990 285 288
2. B. Bülow, L. Hagmar, Z. Mikoczy, C.H. Nordstrom, and E.M. Erfurth Increased cerebrovascular mortality in patients with hypopituitarism Clin. Endocrinol. (Oxf) 46 1997 75 81
3. A.S. Bates, B. Bullivant, R.N. Clayton, M.C. Sheppard, and P.M. Stwert Increased mortality in hypopituitarism is not due to an increase in vascular mortality J. Endocrinol. 152 Suppl. 1997 OC9
4. A.S. Bates, W. Van't Hoff, P.J. Jones, and R.N. Clayton The effect of hypopituitarism of life expectancy J. Clin. Endocrinol. Metab. 81 1996 1169 1172
5. J.W. Tomlinson, N. Holden, and R.K. Hills Association between premature mortality and hypopituitarism Lancet 357 2001 425 431
6. T. Rosén, S. Edén, G. Larson, L. Wilhelmsen, and B.-Å. Bengtsson Cardiovascular risk factors in adult patients with growth hormone deficiency Acta Endocrinol. 129 1993 195 200
7. V. Markussis, S.A. Beshyam, C. Fisher, P. Sharp, N.A. Nicolaides, and D.G. Johnston Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults Lancet 340 1992 1188 1192
8. A. Binnerts, P. Deurenberg, G.R. Swart, J.H.P. Wilson, and S.W.J. Lamberts Body composition in growth hormone-deficient adults Am. J. Clin. Nutr. 55 1992 918 923
9. J.-O. Johanson, J. Fowelin, K. Landin, I. Larger, and B.-Å. Bengtsson Growth hormone deficient adults are insulin-resistant Metabolism 44 1995 1126 1129
10. J.-O. Johansson, K. Landin, L. Tengborn, T. Rosén, and B.-Å. Bengtsson High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults Arterioscler. Thromb. 14 1994 434 437
11. R.C. Cuneo, F. Salomon, C.M. Wiles, R. Hesp, and P.H. Sönksen Growth hormone treatment in growth hormone deficient adults: II. Effects on exercise performance J. Appl. Physiol. 70 1991 695 700
12. P.V. Carrol, E.R. Christ, and B.-Å. Bengtsson Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee J. Clin. Endocrinol. Metab. 83 1998 382 385
13. N. Vahl, J.O.L. Jorgensen, and T.B. Hansen The favorable effects of growth hormone (GH) substitution on hypercholesterolemia in GH-deficient adults are not associated with concomitant reductions in adiposity. A 12 month placebo-controlled study Int. J. Obes. 22 1998 529 536
14. A. Colao, C. Di Somma, and R. Pivonello The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study J. Clin. Endocrinol. Metab. 87 2002 1088 1093
15. G. Amato, G. Mazziotti, and C. Di Somma Recombinant growth hormone (GH) therapy in GH deficient adults: a long-term controlled study on daily versus thrice weekly injections J. Clin. Endocrinol. Metab. 85 2000 3720 3725
16. R.C. Cuneo, F. Salomon, G.F. Watts, R. Hesp, and P.H. Sönksen Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency Metabolism 42 1993 1519 1523
17. V. Markussis, S.A. Beshyah, C. Fisher, K.H. Parker, N.A. Nicolaides, and D.G. Johnston Abnormal carotid arterial wall dynamics in symptom-free hypopituitary adults Eur. J. Endocrinol. 136 1997 157 164
18. B. Capaldo, L. Patti, and U. Oliviero Increased arterial intima-media thickness in childhood onset growth hormone deficiency J. Clin. Endocrinol. Metab. 82 1997 1378 1381
19. S.A. Beshyah Is cardiovascular mortality increased in hypopituitary adults? J.P. Monson Challenges in growth hormone therapy 1999 Blackwell Science Philadelphia 93 105
20. F. Salomon, R.C. Cuneo, R. Hesp, and P.H. Sönksen The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency N. Engl. J. Med. 321 1989 1797 1803
21. J.O.L. Jørgensen, S.A. Pedersen, and L. Thuesen Beneficial effect of growth hormone treatment in GH-deficient adults Lancet 1 1989 1221 1225
22. A. Binnerts, G.R. Swart, and J.H.P. Wilson The effects of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition Clin. Endocrinol. 37 1992 79 87
23. P. Pignoli, H. Tremoli, A. Poli, P. Oreste, and R. Paoletti Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging Circulation 74 1986 1399 1406
24. W.T. Friedewald, R.I. Levy, and D.S. Friedrickson Estimation of the concentration of low density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge Clin. Chem. 18 1972 499 502
25. J.T. Salonen, and R. Salonen Ultrasound B-mode imaging in observational studies of atherosclerotic progression Circulation 87 Suppl. II 1993 II-56 II-65
26. D.E. Grobbee, and M.L. Blots Carotid artery intima-media thickness as an indicator of generalized atherosclerosis J. Intern. Med. 236 1994 567 573
27. G. Geroulakos, D. O'Gorman, A. Nicolaides, D. Sheridan, R. Elkelest, and A.G. Shaper Carotid intima-media thickness: correlation with the British Regional Heart Study risk score J. Intern. Med. 235 1994 431 433
28. J.J. Ricotta, F.A. Bryan, and M.G. Bond Multicenter validation study of real time (B-mode) ultrasound, arteriography, and pathological examination J. Vasc. Surg. 6 1987 512 520
29. J.T. Salonen, and R. Salonen Ultrasonographically assessed carotid morphology and the risk of coronary heart disease Arterioscler. Thromb. 11 1991 1245 1249
30. S. Glagov, C. Zarins, D.P. Giddens, and D.N. Ku Hemodynamics and atherosclerosis: insights and perspectives gained from studies of human arteries Arch. Pathol. Lab. Med. 112 1988 1018 1031
31. M. Pfeifer, R. Verhovec, B. Żižek, J. Preželj, P. Poredoš, and R.N. Clayton Growth (GH) hormone treatment reverses early atherosclerotic changes in GH-deficient adults J. Clin. Endocrinol. Metab. 84 1999 453 457
32. M. Murata, H. Kaji, and I. Mizuno A study of carotid intima-media thickness in GH-deficient Japanese adults during onset among adults and children Eur. J. Endocrinol. 148 2003 333 338
33. R. Lanes, P. Gunczler, E. Lopez, S. Esaa, O. Villaroel, and R. Revel-Chion Cardiac mass and function, carotid artery intima-media thickness and lipoprotein levels in growth hormone-deficient adolescents J. Clin. Endocrinol. Metab. 86 2001 1061 1065
34. B. Bülow, L. Hagmar, J. Eskilsson, and E.M. Erfurth Hypopituitary females have a high incidence of cardiovascular morbidity and increased prevalence of cardiovascular risk factors J. Clin. Endocrinol. Metab. 85 2000 574 584
35. T.A. Elhadd, T.A. Abdu, and J. Oxtoby Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency J. Clin. Endocrinol. Metab. 86 2001 4223 4232
36. M. Leonsson, J. Hulthe, and J. Oscarsson Intima-media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors Clin. Endocrinol. 57 2002 751 759
37. F. Borson-Chazot, A. Serusclat, and Y. Kalfallah Decrease in carotid intima-media thickness after one year growth hormone (GH) treatment in adults with GH deficiency J. Clin. Endocrinol. Metab. 84 1999 1329 1333
38. J. Gibney, J.D. Wallace, and T. Spinks The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients J. Clin. Endocrinol. Metab 84 1999 2596 2602
39. L.M. Evans, J.S. Davies, J. Goodfellow, J.A.E. Rees, and M.F. Scanlon Endothelial dysfunction in hypopituitary adults with growth hormone deficiency Clin. Endocrinol. 50 1999 457 464
40. J.C. Smith, L.M. Evans, and I. Wilkinson Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficiency adults: a randomized, double-blind, placebo-controlled study Eur. J. Endocrinol. 142 2000 254 262
41. B. Healy Endothelial cell dysfunction: an emerging endocrinopathy linked to coronary disease J. Am. Coll. Cardiol. 16 1990 357 358
42. T.J. Anderson Nitric oxide, atherosclerosis and clinical relevance of endothelial dysfunction Heart Fail. Rev. 8 2003 71 86
43. R.H. Boger, C. Skamira, S.M. Bode-Boger, G. Brabant, A. von zur Muhlen, and J.C. Frolich Nitric oxide may mediate hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study J. Clin. Endocrinol. Invest. 98 1996 2706 2713
44. B. Capaldo, V. Guardasole, and F. Pardo Abnormal vascular reactivity in growth hormone deficiency Circulation 103 2001 520 526
45. R.W. McCallum, J.R. Petrie, A.F. Dominiczak, and J.M.C. Connell Growth hormone deficiency and vascular risk Clin. Endocrinol. 57 2002 11 24
46. D. O'Neal, F.L. Few, and K. Silkaris Low density lipoprotein particle size in hypopituitary adults receiving conventional hormone replacement therapy J. Clin. Endocrinol. Metab. 81 1996 2448 2454
47. T. Kearney, C.N. Gallegos, and A. Chrisoulidou Hypopituitarism is associated with triglyceride enrichment of very low-density lipoprotein J. Clin. Endocrinol. Metab. 86 2001 3900 3906
48. L.M. Evans, J.S. Davies, and R.A. Anderson The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency Eur. J. Endocrinol. 142 2000 254 262
49. R. Ross Atherosclerosis-an inflammatory disease N. Engl. J. Med 340 1999 115 126
50. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N. Engl. J. Med. 342 2000 836 843
51. J.-O. Johansson, K. Landin, G. Johannsson, L. Tengborn, and B.-Å. Bengtsson Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults Thromb. Haemost. 76 1996 422 428
52. G. Sesmilo, B.M. Biller, and J. Llevadot Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial Ann. Intern. Med. 133 2000 111 122
53. H. De Boer, G.J. Blok, H.J. Voerman, M. Philips, and J.A. Schouten Serum lipid levels in growth hormone-deficient men Metabolism 43 1994 199 203
54. J. Svensson, J. Fowelin, K. Landin, B.-Å. Bengtsson, and J.-O. Johansson Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults J. Clin. Endocrinol. Metab. 87 2002 2121 2127
55. K.A.S. Al-Shoumer, K.H. Cox, C.L. Hughes, W. Richmond, and D.G. Johnston Fasting and postprandial lipid abnormalities in hypopituitary women receiving conventional replacement therapy J. Clin. Endocrinol. Metab. 82 1997 2653 2659
56. M. Rudling, G. Norstedt, H. Olivecrona, E. Reihnér, J.-Å. Gustafsson, and Bo. Angelin Importance of growth hormone for the induction of hepatic low density lipoprotein receptors Proc. Natl. Acad. Sci. U. S. A. 89 1992 6983 6987
57. E.R. Christ, M.H. Cummings, and D.L. Russel-Jones Dyslipidaemia in adult growth hormone (GH) deficiency and the effect of GH replacement therapy: a review Trends Endocrinol. Metab. 9 1998 200 206
58. A.F. Attanasio, P.C. Bates, and K.K.Y. Ho Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status-3-year results from the HypoCCS database J. Clin. Endocrinol. Metab. 87 2002 1600 1606
59. R.D. Murray, G.E. Wieringa, C.A. Lissett, K.H. Darzy, L.E. Smethurst, and M.S. Shalet Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome Clin. Endocrinol. 56 2002 525 532
60. G. Johannsson, J. Oscarsson, and T. Rosén Effects of 1 year of growth hormone therapy on serum lipoprotein levels in growth hormone-deficient adults. Influence of gender and apo(a) and apoE phenotypes Arterioscler. Thromb. Vasc. Biol. 15 1995 2142 2150
61. D. Florakis, V. Hung, and G. Kaltsas Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study Clin. Endocrinol. 53 2000 453 459
62. D.N. O'Neal, F.L. Hew, J.D. Best, and F. Aford The effect of 24 months' recombinant human growth hormone (rh-GH) on LDL cholesterol, triglyceride-rich lipoproteins and apo[a] in hypopituitary adults previously treated with conventional replacement therapy Growth Horm. IGF Res. 9 1999 165 173
63. J. Koranyi, J. Svensson, G. Götherström, K.S. Sunnerhagen, B.-Å. Bengtsson, and G. Johannsson Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study J. Clin. Endocrinol. Metab. 86 1999 4693 4699
64. K.A.S. Al-Shoumer, R. Gray, and V. Anyaoku Effects of four years' treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults Clin. Endocrinol. 48 1998 795 802
65. G. Götherström, J. Svensson, and J. Koranyi A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass and metabolic indices J. Clin. Endocrinol. Metab. 86 2001 4657 4665
66. W. Nolte, C. Rädisch, V.W. Armstrong, M. Hüfner, and A. von zur Mühlen The effect of recombinant human GH replacement therapy on lipoprotein(a) and other lipid parameters in adults with acquired GH deficiency: results of a double-blind and placebo-controlled trial Eur. J. Endocrinol. 137 1997 459 466
67. P. Garry, P. Collins, and J.D. Devlin An open 36-month study of lipid changes with growth hormone in adults: lipid changes following replacement of growth hormone in adults acquired growth hormone deficiency Eur. J. Endocrinol. 134 1996 61 66
68. A. Chirsoulidou, S.A. Beshyah, and O. Rutherford Effects of 7 years of growth hormone replacement therapy in hypopituitary adults J. Clin. Endocrinol. Metab. 85 2000 3762 3769
69. G. Johansson, T. Rosen, G. Lindstedt, I. Bosaeus, and B.-Å. Bengtsson Effect of 2 years of growth hormone treatment on body composition and cardiovascular risk factors in adults with growth hormone deficiency Endocrinol. Metab. 4 Suppl. A 1996 3 12
70. P. Burman, A.G. Johansson, A. Siegbahn, B. Vessby, and F.A. Karlsson Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women J. Clin. Endocrinol. Metab. 82 1997 550 555
71. J.M. Webster, M. Stewart, and M. Al-Maskari The effect of growth hormone replacement therapy for up to 12 months on lipoprotein composition and lipoprotein(a) in growth hormone deficient adults Atherosclerosis 133 1997 115 121
72. S.A. Beshyah, A. Henderson, and R. Niththyananthan The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance J. Clin. Endocrinol. Metab. 80 1995 356 363
73. E. Modigliani, R. Kerchouni, B. Uzzan, P. Valensi, P. Chanson, and J. Caron Modification of blood lipids and lipoproteins after human growth hormone treatment in adults with growth hormone deficiency: a preliminary report Endocrinol. Metab. 1 Suppl. A 1994 31 35
74. J.U. Weaver, J.P. Monson, and K. Noonan The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults J. Clin. Endocrinol. Metab. 80 1995 153 159
75. B.-Å. Bengtsson, R. Abs, and H. Bennmarker The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults J. Clin. Endocrinol. Metab. 84 1999 3929 3935
76. P. Angerer, S. Störk, W. Kothny, P. Schimitt, and C. von Schacky Effects of oral postmenopausal hormone replacement on progression of atherosclerosis Arterioscler. Thromb. Vasc. Biol. 21 2001 262 268
77. D.H. Blankenhorn, R.H. Selzer, and D.W. Crawford Beneficial effects of cholestipol-niacin therapy on the common carotid artery Circulation 88 1993 20 28
78. H.N. Hodis, W.J. Mack, and L. LaBree Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial Ann. Intern. Med. 124 1996 548 556